When the Medication Turns Down the Volume on Everything Feb 27, 2026 What GLP-1 Drugs Are Teaching Us About the Joy We Lost Long Before the Injection By Sonja Irina Johansen There's a lot of chatter right now about GLP-1 medications Ozempic, Wegovy, Mounjaro, Zepbound and depression
Key Influencing Factors Metabolic rate Genetic predisposition Diet and nutrition Physical activity level Hydration status Treatment area size and fat density Number of sessions performed Adherence to aftercare protocols Most patients require multiple sessions to achieve optimal contouring outcomes, followed by maintenance treatments as needed
Although patients may regain nearly two-thirds of their lost weight on GLP-1 RAs after cessation of the drug 16 , this early positive reinforcement may serve as an incentive to pursue a long-term, multipronged approach to combat obesity
Irregular sleep, chronic stress, physical demands that would sideline most peopleyour job doesnt care about optimal recovery conditions
Maintenance, non-dietary cause: 1mg every two to three months for life
Presented for research literature review only Ian O et al